Comparison between ANG Lifesciences IPO and Nouritrans Exim IPO.
ANG Lifesciences IPO is a SME Fixed Price IPO proposed to list at BSE SME while Nouritrans Exim IPO is a SME Fixed Price proposed to list at BSE SME.
| ANG Lifesciences IPO | Nouritrans Exim IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Fixed Price | Fixed Price |
| Listing At | BSE SME | BSE SME |
| Lead Managers | Oneview Corporate Advisors Pvt.Ltd. | First Overseas Capital Ltd. |
| Registrar | Bigshare Services Pvt.Ltd. | Kfin Technologies Ltd. |
| Market Maker | Guiness Securities Ltd. | Guiness Securities Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Anchor Investor | ||
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of ANG Lifesciences IPO is up to ₹11.39 Cr whereas the issue size of the Nouritrans Exim IPO is up to ₹5.81 Cr. The final issue price of ANG Lifesciences IPO is ₹80.00 per share and of Nouritrans Exim IPO is ₹30.00 per share.
| ANG Lifesciences IPO | Nouritrans Exim IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ||
| Issue Price (Upper) | ||
| Issue Price (Final) | ₹80.00 per share | ₹30.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 1600 shares | 4000 shares |
| Fresh Issue Size | 14,24,000 shares | 19,36,000 shares |
| Fresh Issue Size (Amount) | up to ₹11.39 Cr | up to ₹5.81 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 14,24,000 shares | 19,36,000 shares |
| Issue Size Total (Amount) | up to ₹11.39 Cr | up to ₹5.81 Cr |
ANG Lifesciences IPO opens on Aug 29, 2017, while Nouritrans Exim IPO opens on Sep 04, 2017. The closing date of ANG Lifesciences IPO and Nouritrans Exim IPO is Aug 31, 2017, and Sep 07, 2017, respectively.
| ANG Lifesciences IPO | Nouritrans Exim IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Aug 29, 2017 | Sep 04, 2017 |
| Issue Close | Aug 31, 2017 | Sep 07, 2017 |
| Basis Of Allotment (Tentative) | ||
| Initiation of Refunds (Tentative) | ||
| Credit of Share (Tentative) | ||
| Listing date (Tentative) | Sep 08, 2017 | Sep 15, 2017 |
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
ANG Lifesciences IPO P/E ratio is , as compared to Nouritrans Exim IPO P/E ratio of .
| ANG Lifesciences IPO | Nouritrans Exim IPO | |
|---|---|---|
| Financials | ||
| Promoter Shareholding (Pre-Issue) | ||
| Promoter Shareholding (Post-Issue) | ||
| P/E Ratio | ||
| Market Cap | ||
| ROE | ||
| ROCE | ||
| Debt/Equity | ||
| EPS | ||
| RoNW |
In the ANG Lifesciences IPO Retail Individual Investors (RII) are offered 7,12,000 shares while in Nouritrans Exim IPO retail investors are offered 7,12,000 shares. Qualified Institutional Buyers (QIB) are offered in ANG Lifesciences IPO and in Nouritrans Exim IPO.
| ANG Lifesciences IPO | Nouritrans Exim IPO | |
|---|---|---|
| Anchor Investor Reserveration | ||
| Market Maker Reserveration | 76,800 shares | 1,04,000 shares |
| QIB | ||
| NII | 7,12,000 shares | 9,68,000 shares |
| RII | 7,12,000 shares | 9,68,000 shares |
| Employee | ||
| Others | ||
| Total | 14,24,000 shares | 19,36,000 shares |
ANG Lifesciences IPO subscribed in total, whereas Nouritrans Exim IPO subscribed .
| ANG Lifesciences IPO | Nouritrans Exim IPO | |
|---|---|---|
| QIB (times) | ||
| NII (times) | ||
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | ||
| Employee (times) | ||
| Other (times) | ||
| Total (times) |
Free Equity Delivery
Flat ₹10 per Trade in Intraday & F&O
